MEK-inhibitor treatment reduces the induction of regulatory T cells in mice after influenza A virus infection by Julia Koch-Heier, Julia Koch-Heier, Annette B. Vogel, Yvonne Füll, Marina Ebensperger, Annika Schönsiegel, Annika Schönsiegel, Raphael S. Zinser, Oliver Planz

Get full text

Inactivation of SARS-CoV-2 through Treatment with the Mouth Rinsing Solutions ViruProX^® and BacterX^® Pro by Julia Koch-Heier, Helen Hoffmann, Michael Schindler, Adrian Lussi, Oliver Planz

Get full text

Influenza A virus replication has a stronger dependency on Raf/MEK/ERK signaling pathway activity than SARS-CoV-2 by Helen Hoffmann, Helen Hoffmann, Marina Ebensperger, Annika Schönsiegel, Annika Schönsiegel, Hazem Hamza, Hazem Hamza, Julia Koch-Heier, Julia Koch-Heier, André Schreiber, Stephan Ludwig, Michael Schindler, Oliver Planz

Get full text

Pharmacokinetics, Pharmacodynamics and Antiviral Efficacy of the MEK Inhibitor Zapnometinib in Animal Models and in Humans by Julia Koch-Heier, Julia Koch-Heier, Annika Schönsiegel, Annika Schönsiegel, Lara Maria Waidele, Lara Maria Waidele, Julian Volk, Julian Volk, Yvonne Füll, Christian Wallasch, Sebastian Canisius, Michael Burnet, Oliver Planz, Oliver Planz

Get full text

Establishment of a novel method to assess MEK1/2 inhibition in PBMCs for clinical drug development by Lara M. Schüssele, Lara M. Schüssele, Julia Koch-Heier, Julia Koch-Heier, Julian Volk, Julian Volk, Markus W. Löffler, Markus W. Löffler, Markus W. Löffler, Markus W. Löffler, Katharina Hoffmann, Regina M. Bruyns, Oliver Planz

Get full text